Jeffrey Lisse

5.3k total citations · 1 hit paper
84 papers, 3.8k citations indexed

About

Jeffrey Lisse is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Jeffrey Lisse has authored 84 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Rheumatology, 30 papers in Immunology and 14 papers in Hematology. Recurrent topics in Jeffrey Lisse's work include Rheumatoid Arthritis Research and Therapies (26 papers), Spondyloarthritis Studies and Treatments (22 papers) and Psoriasis: Treatment and Pathogenesis (18 papers). Jeffrey Lisse is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (26 papers), Spondyloarthritis Studies and Treatments (22 papers) and Psoriasis: Treatment and Pathogenesis (18 papers). Jeffrey Lisse collaborates with scholars based in United States, Canada and United Kingdom. Jeffrey Lisse's co-authors include Terry A. McNearney, John D. Reveille, Alan Friedman, Holly M. Bastian, Gerald McGwin, Jeffrey M. Roseman, Barri J. Fessler, Karin N. Westlund, James D. McKay and Neil M. Ampel and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Jeffrey Lisse

80 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis

2016 369 citations John N. Galgiani, Neil M. Ampel et al. profile →

Peers

Countries citing papers authored by Jeffrey Lisse

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Lisse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Lisse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Lisse more than expected).

Fields of papers citing papers by Jeffrey Lisse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Lisse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Lisse. The network helps show where Jeffrey Lisse may publish in the future.

Co-authorship network of co-authors of Jeffrey Lisse

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Lisse. A scholar is included among the top collaborators of Jeffrey Lisse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Lisse. Jeffrey Lisse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis 2024 ·Lara D. Veeken ·Dennis McGonagle, Arthur Kavanaugh, Iain B. McInnes, Lars Erik Kristensen, Joseph F. Merola, Bruce Strober, Rebecca Bolce, Jeffrey Lisse, (unknown), Christophe Sapin, Christopher T. Ritchlin	2
2	Employment, Work Productivity, and Biologic Treatments in Self-Reported Axial Spondyloarthritis: a Cross-Sectional Study in a Female Predominant Population from the ArthritisPower Registry 2022 ·Rheumatology and Therapy ·Kelly Gavigan, W. Benjamin Nowell, Theresa Hunter, Jeffrey R. Curtis, William N. Malatestinic, Rebecca Bolce, Jeffrey Lisse, Jessica A. Walsh	7
3	Identifying inadequate response among patients with ankylosing spondylitis and psoriatic arthritis prescribed advanced therapy in a real-world, commercially insured adult population in the USA 2022 ·Clinical Rheumatology ·Theresa Hunter, Michael Grabner, Julie Birt, Keith Isenberg, (unknown), Chia‐Chen Teng, Jianmin Wu, (unknown), Jeffrey Lisse, Jeffrey R. Curtis	4
4	Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis 2022 ·The Lancet Rheumatology ·Walter P. Maksymowych, Xenofon Baraliakos, R. Lambert, Robert Landewé, David Sandoval, Hilde Carlier, Jeffrey Lisse, Xiaoqi Li, Maja Hojnik, Mikkel Østergaard	15
5	Pain Medication and Corticosteroid Use in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis in the United States: A Retrospective Observational Study 2021 ·Rheumatology and Therapy ·Theresa Hunter, (unknown), Julie Birt, Joseph A. Smith, Mingyang Shan, Hiangkiat Tan, Jeffrey Lisse, Keith Isenberg	12
6	Management of asymptomatic coccidioidomycosis in patients with rheumatic diseases 2019 ·Rheumatology International ·Jawad Bilal, (unknown), Barbara Bode, Jeffrey Lisse, Susan E. Hoover, (unknown), Neil M. Ampel	4
7	Long‐term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus 2012 ·Arthritis & Rheumatism ·Joan T. Merrill, Ellen M. Ginzler, Daniel J. Wallace, James D. McKay, Jeffrey Lisse, Cynthia Aranow, (unknown), (unknown), John J. Condemi, Z. John Zhong, Lilia Pineda, Jerry L. Klein, William W. Freimuth, (unknown)	88
8	Management of coccidioidomycosis in patients receiving biologic response modifiers or disease‐modifying antirheumatic drugs 2012 ·Arthritis Care & Research ·(unknown), (unknown), Jeffrey Lisse, (unknown), Neil M. Ampel, (unknown), John N. Galgiani, Susan E. Hoover	36
9	Biologics and postbiologics: novel immunotherapeutics for the induction and maintenance of remission 2009 ·Drug Discovery Today ·Willem van Eden, Jeffrey Lisse, Berent J. Prakken, Salvatore Albani	6
10	Abatacept in the treatment of rheumatoid arthritis 2008 ·Expert Review of Clinical Immunology ·(unknown), Jeffrey Lisse, Sujata Sarkar	4
11	Self‐Reported Osteoarthritis, Ethnicity, Body Mass Index, and Other Associated Risk Factors in Postmenopausal Women—Results from the Women's Health Initiative 2008 ·Journal of the American Geriatrics Society ·Nicole C. Wright, (unknown), Jeffrey Lisse, Zhao Chen	31
12	Mechanical sensation and pain thresholds in patients with chronic arthropathies 2003 ·Journal of Pain ·(unknown), Karin N. Westlund, Nada Lawand, Niti Goel, Jeffrey Lisse, Terry A. McNearney	100
13	Pericardial Effusion and Cardiomyopathy Following Arthritis with Parvovirus B19 Infection: Response to Intravenous Immunoglobulin 2001 ·JCR Journal of Clinical Rheumatology ·(unknown), Niti Goel, Jeffrey Lisse, Terry A. McNearney	2
14	Systemic lupus erythematosus in three ethnic groups: IX. Differences in damage accrual 2001 ·Arthritis & Rheumatism ·(unknown), Gerald McGwin, Alfred A. Bartolucci, Jeffrey M. Roseman, Jeffrey Lisse, Barri J. Fessler, Holly M. Bastian, Alan Friedman, John D. Reveille, (unknown)	207
15	Systemic lupus erythematosus in three ethnic groups. VIII. Lack of association of glutathione S-transferase null alleles with disease manifestations 2001 ·Arthritis & Rheumatism ·(unknown), Chul Woo Ahn, Alan Friedman, John D. Reveille, Filemon K. Tan, (unknown), Holly M. Bastian, Barri J. Fessler, Gerald McGwin, Jeffrey Lisse	10
16	Systemic sclerosis in 3 US ethnic groups: A comparison of clinical, sociodemographic, serologic, and immunogenetic determinants 2001 ·Seminars in Arthritis and Rheumatism ·John D. Reveille, Michael A. Fischbach, Terry A. McNearney, Alan Friedman, (unknown), Jeffrey Lisse, Marvin J. Fritzler, Chul Ahn, Frank C. Arnett	198
17	Excitatory and inhibitory amino acid profiles of synovial fluids derived from patients with arthritis 1999 ·Journal of Investigative Medicine ·Terry A. McNearney, (unknown), Nada Lawand, Jeffrey Lisse, Karin N. Westlund	1
18	Gout masquerading as rheumatoid vasculitis. 1994 ·PubMed ·Arun Kumar Sharma, Bruce A. Baethge, (unknown), Mary Shepherd, Jeffrey Lisse	6
19	Achromobacter xylosoxidans septic arthritis in a patient with systemic lupus erythematosus 1991 ·Arthritis & Rheumatism ·(unknown), (unknown), (unknown), Jeffrey Lisse	10
20	Deep Venous Thrombosis in Intravenous Cocaine Abuse Mimicking Septic Arthritis of the Shoulder 1991 ·Southern Medical Journal ·Jeffrey Lisse, (unknown), Charles P. Davis	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact